HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

J Speyer Selected Research

Monoclonal Antibodies

3/2007A phase II trial of EMD72000 (matuzumab), a humanized anti-EGFR monoclonal antibody, in patients with platinum-resistant ovarian and primary peritoneal malignancies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


J Speyer Research Topics

Disease

1Acne Vulgaris
03/2007
1Diarrhea
03/2007
1Exanthema (Rash)
03/2007
1Fatigue
03/2007
1Headache (Headaches)
03/2007
1Neoplasms (Cancer)
03/2007
1Paronychia
03/2007

Drug/Important Bio-Agent (IBA)

1matuzumabIBA
03/2007
1Monoclonal AntibodiesIBA
03/2007
1PlatinumIBA
03/2007

Therapy/Procedure

1Therapeutics
03/2007